IV Iron Sucrose, our iron sucrose injection product, is a complex of polynuclear iron (III)-hydroxide in a sucrose solution for intravenous administration. IV Iron Sucrose is indicated for the treatment of iron deficiency anemia. Compared to other forms of iron supplements such as oral iron supplements and iron dextran injections, iron sucrose injections have quicker onset, better efficacy, fewer side effects and more efficient iron absorption. As an intravenously administered drug, IV Iron Sucrose is especially suitable for patients who are unable to tolerate or effectively absorb orally administered iron supplements. IV Iron Sucrose can be prescribed in combination with EPIAO for late-stage CKD patients suffering from anemia or for patients with late-stage iron deficiency. IV Iron Sucrose is included in the National Medical Insurance Catalogue as a Category B drug.
According to IMS, IV Iron Sucrose ranked third in terms of sales in the PRC iron sucrose injection market in each of these periods and grew at a faster rate than each of its larger competitors from 2009 to 2013.